R: Bayesian Designs for Early Phase Clinical Trials

# Bayesian Designs for Early Phase Clinical Trials

## Documentation for package ‘Keyboard’ version 0.1.3

- DESCRIPTION file

## Help Pages

decision.finding | Return Dose Escalation or De-escalation Decision Given Number of Toxicity and Responses
example.kb | Illustration of the Keyboard Design (Single-agent)
get.boundary.comb.kb | Dose Escalation or De-escalation Boundaries for Drug-combination Trials
get.boundary.kb | Dose Escalation or De-escalation Boundaries for Single-agent Trials
get.decision.obd.kb | Boundary Table and Decision Matrix for Phase I/II Trials.
get.decision.obd2.kb | Automatic Boundary and Decision Tables for Phase I/II Trials.
get.oc.comb.kb | Operating Characteristics for Drug-combination Trials
get.oc.kb | Operating Characteristics for Single-agent Trials
get.oc.obd.kb | Generate Operating Characteristics to Find the Optimal Biological Dose
get.oc.obd2.kb | Generate Operating Characteristics for OBD Finding Automaticallly
next.comb.kb | Find the Next Dose Combination
plot_kb | Plot Objects Generated by the Keyboard Design Package
select.mtd.comb.kb | Maximum Tolerated Dose (MTD) Selection for Drug-combination Trials
select.mtd.kb | Maximum Tolerated Dose (MTD) Selection for Single-agent Trials
select.obd.kb | Select the Optimal Biological Dose (OBD) for Single-agent Phase I/II Trials
summary_kb | Summarize Objects Generated by the Keyboard Design Package